��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
瑞穎(8083)
月營收
季盈餘
2025/02/01
169.0元 (瑞穎股價)
2025/02/01
-17.30%
(年增率)
103百萬元 (營收)
瑞穎(8083) 年度營收走勢圖
瑞穎(8083)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/02
103,128
38.16%
124,701
-17.30%
177,771
-27.09%
114/01
74,643
-26.61%
119,136
-37.35%
74,643
-37.35%
113/12
101,708
3.71%
92,666
9.76%
1,467,107
33.34%
113/11
98,071
5.93%
86,478
13.41%
1,365,399
35.50%
113/10
92,577
11.20%
93,783
-1.29%
1,267,328
37.58%
113/09
83,249
-17.01%
118,075
-29.49%
1,174,751
41.98%
113/08
100,310
-19.83%
115,059
-12.82%
1,091,502
53.88%
113/07
125,126
0.26%
101,217
23.62%
991,192
66.80%
113/06
124,798
-20.46%
98,228
27.05%
866,066
75.66%
113/05
156,896
-7.05%
90,217
73.91%
741,268
87.76%
113/04
168,792
-1.72%
72,321
133.39%
584,372
91.86%
113/03
171,743
37.72%
97,076
76.92%
415,580
78.92%
113/02
124,701
4.67%
75,041
66.18%
243,837
80.37%
113/01
119,136
28.56%
60,148
98.07%
119,136
98.07%
112/12
92,666
7.16%
80,012
15.82%
1,100,309
-34.27%
112/11
86,478
-7.79%
80,088
7.98%
1,007,643
-36.79%
112/10
93,783
-20.57%
90,232
3.94%
921,165
-39.15%
112/09
118,075
2.62%
110,382
6.97%
827,382
-41.89%
112/08
115,059
13.68%
150,080
-23.33%
709,307
-45.99%
112/07
101,217
3.04%
150,073
-32.55%
594,248
-48.92%
112/06
98,228
8.88%
175,139
-43.91%
493,031
-51.34%
112/05
90,217
24.75%
156,525
-42.36%
394,803
-52.89%
112/04
72,321
-25.50%
151,484
-52.26%
304,586
-55.31%
112/03
97,076
29.36%
194,579
-50.11%
232,265
-56.18%
112/02
75,041
24.76%
149,720
-49.88%
135,189
-59.70%
112/01
60,148
-24.83%
185,735
-67.62%
60,148
-67.62%
111/12
80,012
-0.09%
144,661
-44.69%
1,674,049
-26.83%
111/11
80,088
-11.24%
189,328
-57.70%
1,594,037
-25.62%
111/10
90,232
-18.25%
160,148
-43.66%
1,513,949
-22.52%
111/09
110,382
-26.45%
194,050
-43.12%
1,423,717
-20.63%
111/08
150,080
0.00%
190,074
-21.04%
1,313,335
-17.90%
111/07
150,073
-14.31%
180,339
-16.78%
1,163,255
-17.48%
111/06
175,139
11.89%
219,655
-20.27%
1,013,182
-17.58%
111/05
156,525
3.33%
218,258
-28.28%
838,043
-16.99%
111/04
151,484
-22.15%
217,572
-30.38%
681,518
-13.88%
111/03
194,579
29.96%
210,185
-7.42%
530,034
-7.62%
111/02
149,720
-19.39%
179,639
-16.66%
335,455
-7.74%
111/01
185,735
28.39%
185,735
110/12
144,661
-23.59%
2,287,853
110/11
189,328
18.22%
2,143,192
110/10
160,148
-17.47%
1,953,864
110/09
194,050
2.09%
1,793,716
110/08
190,074
5.40%
1,599,666
110/07
180,339
-17.90%
1,409,592
110/06
219,655
0.64%
1,229,253
110/05
218,258
0.32%
1,009,598
110/04
217,572
3.51%
791,340
110/03
210,185
17.00%
573,768
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
